Sedating a Post-Arrest Patient Without Sedating the Prognosis
A golfer's heart stopped on the ninth hole and started again twelve minutes later. Now his kidneys are hurting, and the sedative keeping him comfortable through targeted temperature management could quietly outlast the exam meant to tell his family what comes next.
S.M., a 55-year-old man, had just finished his tee shot on the ninth hole when he collapsed — a witnessed arrest, bystander CPR started within a minute, an automated defibrillator shock delivered by a fellow golfer who happened to know where the clubhouse kept one, and return of spontaneous circulation after twelve minutes of resuscitation. He arrived comatose and is now eighteen hours into targeted temperature management at 36°C, the wider range the 2025 AHA and ESICM guideline updates adopted after TTM2 found no outcome difference between 33°C and controlled normothermia with fever avoidance — a real, guideline-level shift from the older fixed-33°C protocol this team trained on. What hasn't shifted is the stakes of the exam scheduled for hour 72: neuroprognostication in a comatose post-arrest patient, the conversation his family is waiting on, and one those same 2025 updates tightened by making explicit that sedatives must have cleared, not merely been reduced, before that exam can be trusted.
His creatinine, 1.9 and rising from a presumed normal baseline, is acute kidney injury from the hypoperfusion of his arrest itself — and it bears directly on which sedative gets him cleanly to that 72-hour window rather than confounding it. The risk is not the one the kidney injury first suggests: fentanyl is metabolized hepatically to norfentanyl, which is inactive, and it is for exactly that reason the opioid usually preferred when renal function is poor. What does accumulate is fentanyl itself, into peripheral tissue, so its context-sensitive half-time lengthens the longer an infusion runs — a multi-day infusion can leave him sedated well past 72 hours for reasons that have nothing to do with his neurologic recovery, and his AKI is a reason to watch that timeline rather than the mechanism driving it. Propofol carries the mirror-image version of the same problem, which is why the ESICM's 2025 guidance asks that it be stopped more than 24 hours before the examination — the pharmacologic argument is not that opioid analgesia should stop, but that the infusion strategy has to be built now, at hour 18, around a drug-clearance timeline that protects the honesty of a conversation still four days away.
What the exam at 72 hours will actually mean
He's still being actively cooled and could shiver, which raises his metabolic demand right when we're trying to protect his brain. I don't want to under-sedate him for the sake of an exam that's still four days out. Continue the current fentanyl and propofol infusions, and we simply extend the sedation-holiday window before 72 hours to compensate for slower clearance.
I understand the shivering concern, but 'extend the washout and hope it's long enough' is exactly the approach the updated guideline moved away from by making sedation clearance explicit rather than assumed. If his AKI slows fentanyl's effective clearance more than we predict, a longer fixed hold doesn't fix that — it just delays finding out. I'd rather reduce how much accumulates in the first place.
Both goals are achievable without trading one for the other. Keep propofol as the primary agent for cooling comfort and shivering control — and hold the line that neither drug's clearance here is really a kidney question — then convert fentanyl to scheduled intermittent boluses for analgesia rather than a continuous infusion. That controls today's discomfort and meaningfully limits what has to clear before hour 72, instead of betting the exam's honesty on a longer wait alone.
Propofol continued for cooling comfort with fentanyl converted to intermittent dosing that afternoon. Sedation was held per protocol beginning at hour 60, and by hour 72 his exam was performed with no detectable residual sedative effect on formal assessment.
The ICU attending's shivering concern didn't materialize into a problem — propofol alone controlled it adequately — but the team noted this wasn't guaranteed in advance and credited the earlier regimen change, not the longer washout window that was originally proposed, with making the 72-hour exam one the family could be given without qualification.